サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1553430

酵素DNA合成の市場規模、シェア、動向分析レポート：サービス別、用途別、最終用途別、地域別、セグメント別予測、2024年～2030年

Enzymatic DNA Synthesis Market Size, Share & Trends Analysis Report By Service (Oligonucleotide Synthesis, Gene Synthesis), By Application (Synthetic Biology, Genetic Engineering), By End-use, By Region, And Segment Forecasts, 2024 - 2030

出版日
ページ情報
英文 120 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
酵素DNA合成の市場規模、シェア、動向分析レポート：サービス別、用途別、最終用途別、地域別、セグメント別予測、2024年～2030年
出版日: 2024年08月13日
発行: Grand View Research
ページ情報: 英文 120 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

酵素DNA合成市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界の酵素DNA合成市場は2030年までに11億9,000万米ドルに達すると予測され、2024年から2030年までのCAGRは26.4%で成長する見込みです。

バイオ医薬品研究の増加、DNA合成の進歩、合成生物学分野の拡大が市場成長を促進すると見られています。さらに、精密医療と治療に対する需要の高まりが、予測期間中の市場の需要をさらに促進すると予測されています。

COVID-19パンデミックは、主に診断、ワクチン、治療薬の研究開発を加速させ、市場にプラスの影響を与えました。ウイルスの迅速かつ正確なゲノム配列決定とmRNAワクチンの開発に対する需要が、合成DNAの需要を大幅に押し上げました。さらに、パンデミックは、迅速でスケーラブルかつ正確なDNA合成法の重要性を強調し、酵素合成技術への投資の増加につながった。例えば、2020年7月、DNA ScriptはシリーズBラウンドで5,000万米ドルの資金を確保し、投資総額を8,900万米ドルに引き上げ、合成DNAの世界の供給を推進しました。このような要因が市場の成長を後押ししており、予測期間中にも飛躍的な成長が見込まれます。

さらに、合成生物学の急速な拡大が、酵素DNA合成の需要をさらに押し上げました。これは、合成生物、治療用タンパク質、バイオベース材料など、新規の生物学的システムを工学的に構築する際に使用される複雑な遺伝子配列を正確かつ効率的に構築する必要性が高まっているためです。さらに、酵素的DNA合成は、合成生物学の要求を満たすのに必要なスピード、正確さ、スケーラビリティを提供し、研究者が遺伝子編集、代謝工学、合成ゲノミクスなどの分野でイノベーションを起こすことを可能にします。このような要因が、予測期間中の市場の成長を後押しすると予測されます。

しかし、酵素的DNA合成は製造コストが高く、技術的に複雑であるため、その利用が制限される可能性があります。酵素合成に必要な高度な装置、特殊な試薬、専門知識が運用コストの上昇につながるためです。さらに、合成されたDNA配列の正確さとスケーラビリティーを保証するための複雑なプロセスが、その利用をさらに複雑にし、必要な技術的能力を備えた資金力のある機関や組織のみに利用を制限する可能性があります。その結果、予測期間中の市場の成長を妨げることになります。

酵素DNA合成市場レポートハイライト

  • オリゴヌクレオチド合成セグメントは、遺伝子研究、診断、治療開発など幅広い用途があるため、2023年に最大の市場シェアを占めました。一方、遺伝子合成は予測期間中に最も速いCAGRで成長すると予測されています。
  • 2023年には、合成生物学セグメントがアプリケーションセグメントの市場シェアを独占し、27.5%の最速CAGRで成長すると予測されます。これは、遺伝子編集、治療薬、産業バイオテクノロジーへの応用が増加しているためです。
  • 先端的な治療ソリューションに対する需要の高まり、研究開発への投資の増加、医薬品開発や個別化医療のための最先端バイオテクノロジーの採用により、2023年にはバイオ製薬会社が最終用途セグメントで最大のシェアを占めました。
  • 北米は、バイオテクノロジー、医療、治療における強力な研究開発、多額の政府資金などの要因により、50.11%のシェアで市場を独占しています。アジア太平洋は、予測期間中に最も速いCAGRで成長すると予測されています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 酵素DNA合成市場の変数、動向、範囲

  • 市場系統の見通し
    • 親市場の見通し
    • 関連/付随市場の見通し
  • 市場力学
    • 市場牽引要因分析
    • 市場抑制要因分析
  • 酵素DNA合成市場分析ツール
    • 業界分析- ポーターのファイブフォース分析
    • PESTEL分析
    • COVID-19の影響分析

第4章 酵素DNA合成市場：サービス別推定・動向分析

  • サービス別セグメントダッシュボード
  • 世界の酵素DNA合成市場サービス別変動分析
  • 世界の酵素 DNA合成市場規模と動向分析、サービス別、2018年-2030年
  • オリゴヌクレオチド合成
  • 遺伝子合成

第5章 酵素DNA合成市場：用途別推定・動向分析

  • 用途別セグメントダッシュボード
  • 世界の酵素DNA合成市場の用途別変動分析
  • 世界の酵素 DNA合成市場規模と動向分析、用途別、2018年-2030年
  • 合成生物学
  • ワクチン開発
  • 遺伝子工学
  • その他

第6章 酵素DNA合成市場：最終用途別推定・動向分析

  • 最終用途セグメントダッシュボード
  • 世界の酵素DNA合成市場の最終用途変動分析
  • 世界の酵素 DNA合成市場規模と動向分析、最終用途別、2018年-2030年
  • バイオ医薬品企業
  • 学術研究機関
  • 受託研究機関

第7章 酵素DNA合成市場：サービス、用途、最終用途別の地域推定・動向分析

  • 地域市場ダッシュボード
  • 市場規模と予測動向分析、2018年-2030年
  • 北米
  • 欧州
  • アジア太平洋
  • ラテンアメリカ
  • 中東・アフリカ

第8章 競合情勢

  • 企業/競合の分類
  • 戦略マッピング
  • 企業市況分析、2023年
  • 企業プロファイル/上場企業
    • Telesis Bio Inc.
    • Twist Bioscience Corporation
    • GenScript Biotech Corp.
    • Evonetix
    • Ansa Biotechnologies, Inc.
    • Camena Bio
    • Molecular Assemblies
    • DNA Script
    • Touchlight
    • Kern Systems
図表

List of Tables

  • Table 1 List of abbreviation
  • Table 2 Global enzymatic DNA synthesis market, by region, 2018 - 2030 (USD Million)
  • Table 3 Global enzymatic DNA synthesis market, by services, 2018 - 2030 (USD Million)
  • Table 4 Global enzymatic DNA synthesis market, by application, 2018 - 2030 (USD Million)
  • Table 5 Global enzymatic DNA synthesis market, by end use, 2018 - 2030 (USD Million)
  • Table 6 North America enzymatic DNA synthesis market, by country, 2018 - 2030 (USD Million)
  • Table 7 North America enzymatic DNA synthesis market, by services, 2018 - 2030 (USD Million)
  • Table 8 North America enzymatic DNA synthesis market, by application, 2018 - 2030 (USD Million)
  • Table 9 North America enzymatic DNA synthesis market, by end use, 2018 - 2030 (USD Million)
  • Table 10 U.S. enzymatic DNA synthesis market, by services, 2018 - 2030 (USD Million)
  • Table 11 U.S. enzymatic DNA synthesis market, by application, 2018 - 2030 (USD Million)
  • Table 12 U.S. enzymatic DNA synthesis market, by end use, 2018 - 2030 (USD Million)
  • Table 13 Canada enzymatic DNA synthesis market, by services, 2018 - 2030 (USD Million)
  • Table 14 Canada enzymatic DNA synthesis market, by application, 2018 - 2030 (USD Million)
  • Table 15 Canada enzymatic DNA synthesis market, by end use, 2018 - 2030 (USD Million)
  • Table 16 Europe enzymatic DNA synthesis market, by country, 2018 - 2030 (USD Million)
  • Table 17 Europe enzymatic DNA synthesis market, by services, 2018 - 2030 (USD Million)
  • Table 18 Europe enzymatic DNA synthesis market, by application, 2018 - 2030 (USD Million)
  • Table 19 Europe enzymatic DNA synthesis market, by end use, 2018 - 2030 (USD Million)
  • Table 20 Germany enzymatic DNA synthesis market, by services, 2018 - 2030 (USD Million)
  • Table 21 Germany enzymatic DNA synthesis market, by application, 2018 - 2030 (USD Million)
  • Table 22 Germany enzymatic DNA synthesis market, by end use, 2018 - 2030 (USD Million)
  • Table 23 UK enzymatic DNA synthesis market, by services, 2018 - 2030 (USD Million)
  • Table 24 UK enzymatic DNA synthesis market, by application, 2018 - 2030 (USD Million)
  • Table 25 UK enzymatic DNA synthesis market, by end use, 2018 - 2030 (USD Million)
  • Table 26 France enzymatic DNA synthesis market, by services, 2018 - 2030 (USD Million)
  • Table 27 France enzymatic DNA synthesis market, by application, 2018 - 2030 (USD Million)
  • Table 28 France enzymatic DNA synthesis market, by end use, 2018 - 2030 (USD Million)
  • Table 29 Italy enzymatic DNA synthesis market, by services, 2018 - 2030 (USD Million)
  • Table 30 Italy enzymatic DNA synthesis market, by application, 2018 - 2030 (USD Million)
  • Table 31 Italy enzymatic DNA synthesis market, by end use, 2018 - 2030 (USD Million)
  • Table 32 Spain enzymatic DNA synthesis market, by services, 2018 - 2030 (USD Million)
  • Table 33 Spain enzymatic DNA synthesis market, by application, 2018 - 2030 (USD Million)
  • Table 34 Spain enzymatic DNA synthesis market, by end use, 2018 - 2030 (USD Million)
  • Table 35 Denmark enzymatic DNA synthesis market, by services, 2018 - 2030 (USD Million)
  • Table 36 Denmark enzymatic DNA synthesis market, by application, 2018 - 2030 (USD Million)
  • Table 37 Denmark enzymatic DNA synthesis market, by end use, 2018 - 2030 (USD Million)
  • Table 38 Sweden enzymatic DNA synthesis market, by services, 2018 - 2030 (USD Million)
  • Table 39 Sweden enzymatic DNA synthesis market, by application, 2018 - 2030 (USD Million)
  • Table 40 Sweden enzymatic DNA synthesis market, by end use, 2018 - 2030 (USD Million)
  • Table 41 Norway enzymatic DNA synthesis market, by services, 2018 - 2030 (USD Million)
  • Table 42 Norway enzymatic DNA synthesis market, by application, 2018 - 2030 (USD Million)
  • Table 43 Norway enzymatic DNA synthesis market, by end use, 2018 - 2030 (USD Million)
  • Table 44 Asia Pacific enzymatic DNA synthesis market, by country, 2018 - 2030 (USD Million)
  • Table 45 Asia Pacific enzymatic DNA synthesis market, by services, 2018 - 2030 (USD Million)
  • Table 46 Asia Pacific enzymatic DNA synthesis market, by application, 2018 - 2030 (USD Million)
  • Table 47 Asia Pacific enzymatic DNA synthesis market, by end use, 2018 - 2030 (USD Million)
  • Table 48 China enzymatic DNA synthesis market, by application, 2018 - 2030 (USD Million)
  • Table 49 China enzymatic DNA synthesis market, by services, 2018 - 2030 (USD Million)
  • Table 50 China enzymatic DNA synthesis market, by end use, 2018 - 2030 (USD Million)
  • Table 51 Japan enzymatic DNA synthesis market, by services, 2018 - 2030 (USD Million)
  • Table 52 Japan enzymatic DNA synthesis market, by application, 2018 - 2030 (USD Million)
  • Table 53 Japan enzymatic DNA synthesis market, by end use, 2018 - 2030 (USD Million)
  • Table 54 India enzymatic DNA synthesis market, by services, 2018 - 2030 (USD Million)
  • Table 55 India enzymatic DNA synthesis market, by application, 2018 - 2030 (USD Million)
  • Table 56 India enzymatic DNA synthesis market, by end use, 2018 - 2030 (USD Million)
  • Table 57 South Korea enzymatic DNA synthesis market, by services, 2018 - 2030 (USD Million)
  • Table 58 South Korea enzymatic DNA synthesis market, by application, 2018 - 2030 (USD Million)
  • Table 59 South Korea enzymatic DNA synthesis market, by end use, 2018 - 2030 (USD Million)
  • Table 60 Australia enzymatic DNA synthesis market, by services, 2018 - 2030 (USD Million)
  • Table 61 Australia enzymatic DNA synthesis market, by application, 2018 - 2030 (USD Million)
  • Table 62 Australia enzymatic DNA synthesis market, by end use, 2018 - 2030 (USD Million)
  • Table 63 Latin America enzymatic DNA synthesis market, by country, 2018 - 2030 (USD Million)
  • Table 64 Latin America enzymatic DNA synthesis market, by services, 2018 - 2030 (USD Million)
  • Table 65 Latin America enzymatic DNA synthesis market, by application, 2018 - 2030 (USD Million)
  • Table 66 Latin America enzymatic DNA synthesis market, by end use, 2018 - 2030 (USD Million)
  • Table 67 Brazil enzymatic DNA synthesis market, by services, 2018 - 2030 (USD Million)
  • Table 68 Brazil enzymatic DNA synthesis market, by application, 2018 - 2030 (USD Million)
  • Table 69 Brazil enzymatic DNA synthesis market, by end use, 2018 - 2030 (USD Million)
  • Table 70 Chile enzymatic DNA synthesis market, by services, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Market formulation & validation
  • Fig. 4 Enzymatic DNA synthesis market: Market outlook
  • Fig. 5 Enzymatic DNA synthesis market: Segment outlook
  • Fig. 6 Enzymatic DNA synthesis market: Competitive landscape outlook
  • Fig. 7 Parent market outlook
  • Fig. 8 Enzymatic DNA synthesis market driver impact
  • Fig. 9 Enzymatic DNA synthesis market restraint impact
  • Fig. 10 Enzymatic DNA synthesis market: Services outlook and key takeaways
  • Fig. 11 Enzymatic DNA synthesis market: Services movement analysis
  • Fig. 12 Oligonucleotide synthesis market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 13 Gene synthesis market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 14 Enzymatic DNA synthesis market: Application outlook and key takeaways
  • Fig. 15 Enzymatic DNA synthesis market: Application movement analysis
  • Fig. 16 Synthetic biology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 17 Vaccine development market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 18 Genetic engineering market estimates and forecasts,2018 - 2030 (USD Million)
  • Fig. 19 Others market estimates and forecasts,2018 - 2030 (USD Million)
  • Fig. 20 Enzymatic DNA synthesis market: End use outlook and key takeaways
  • Fig. 21 Enzymatic DNA synthesis market: End use movement analysis
  • Fig. 22 Biopharmaceutical companies market estimates and forecasts,2018 - 2030 (USD Million)
  • Fig. 23 Academic & research institutes market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 24 Contract research organizations market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 Global enzymatic DNA synthesis market: Regional outlook and key takeaways
  • Fig. 26 Global enzymatic DNA synthesis market: Regional movement analysis
  • Fig. 27 North America enzymatic DNA synthesis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 U.S. enzymatic DNA synthesis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 Canada enzymatic DNA synthesis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Europe enzymatic DNA synthesis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 UK enzymatic DNA synthesis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 Germany enzymatic DNA synthesis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 France enzymatic DNA synthesis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Italy enzymatic DNA synthesis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Spain enzymatic DNA synthesis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Denmark enzymatic DNA synthesis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Sweden enzymatic DNA synthesis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Norway enzymatic DNA synthesis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Asia Pacific enzymatic DNA synthesis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 China enzymatic DNA synthesis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Japan enzymatic DNA synthesis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 India enzymatic DNA synthesis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 South Korea enzymatic DNA synthesis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Australia enzymatic DNA synthesis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Latin America enzymatic DNA synthesis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Brazil enzymatic DNA synthesis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Chile enzymatic DNA synthesis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Middle East and Africa enzymatic DNA synthesis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Saudi Arabia enzymatic DNA synthesis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 UAE enzymatic DNA synthesis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Kuwait enzymatic DNA synthesis market estimates and forecasts, 2018 - 2030 (USD Million)
目次
Product Code: GVR-4-68040-411-2

Enzymatic DNA Synthesis Market Growth & Trends:

The global enzymatic DNA synthesis market is anticipated to reach USD 1.19 billion by 2030 and is expected to grow at a CAGR of 26.4% from 2024 to 2030, according to a new report by Grand View Research, Inc. Increasing biopharmaceutical research, advancements in DNA synthesis, and the expanding field of synthetic biology are expected to propel market growth. Moreover, the rising demand for precision medicine and therapeutics is further anticipated to propel the demand for the market over the forecast period.

The COVID-19 pandemic positively impacted the market, primarily by accelerating research & development in diagnostics, vaccines, and therapeutics. The demand for rapid and accurate genomic sequencing of the virus and the development of mRNA vaccines significantly boosted the demand for synthetic DNA. In addition, the pandemic emphasized the significance of quick, scalable, and precise DNA synthesis methods, leading to increased investment in enzymatic synthesis technologies. For instance, in July 2020, DNA Script secured USD 50 million in funding for its Series B round, raising the total investment to USD 89 million, propelling their synthetic DNA supply worldwide. These factors have impelled the market's growth and are anticipated to propel exponentially over the forecast period.

In addition, the rapid expansion of synthetic biology further propelled the demand for enzymatic DNA synthesis. This is attributed to the growing need for precise and efficient construction of complex genetic sequences used in engineering novel biological systems, such as synthetic organisms, therapeutic proteins, and bio-based materials. Furthermore, enzymatic DNA synthesis offers the speed, accuracy, and scalability required to meet the demands of synthetic biology, enabling researchers to innovate in areas like gene editing, metabolic engineering, and synthetic genomics. These factors are thus projected to impel the market's growth over the forecast period.

However, the high cost of producing and technical complexity of enzymatic DNA synthesis might limit their accessibility. These challenges can create barriers to widespread adoption, as the advanced equipment, specialized reagents, and expertise required for enzymatic synthesis contribute to higher operational costs. In addition, the complicated processes involved in ensuring the accuracy and scalability of synthesized DNA sequences may further complicate its use, potentially restricting its availability to only well-funded institutions and organizations with the necessary technical capabilities. Thereby hampering the growth of the market over the forecast period.

Enzymatic DNA Synthesis Market Report Highlights:

  • The oligonucleotide synthesis segment held the largest market share in 2023 due to its wide applications, such as genetic research, diagnostics, and therapeutic development. On the other hand, gene synthesis is anticipated to grow at the fastest CAGR over the forecast period
  • In 2023, the synthetic biology segment is anticipated to dominate the market share for the application segment and is anticipated to grow at the fastest CAGR of 27.5%. This is attributed to the increasing application in gene editing, therapeutics, and industrial biotechnology
  • Biopharmaceutical companies dominated the end use segment with the largest share in 2023 due to the growing demand for advanced therapeutic solutions, increased investment in R&D, and the adoption of cutting-edge biotechnologies for drug development and personalized medicine
  • North America dominated the market with a share of 50.11% owing to factors such as strong R&D in biotechnology, medicine, and therapeutics, along with substantial government funding. Asia Pacific is anticipated to grow at the fastest CAGR over the forecast period.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
    • 1.2.1. Services
    • 1.2.2. Application
    • 1.2.3. End Use
  • 1.3. Information analysis
  • 1.4. Market formulation & data visualization
  • 1.5. Data validation & publishing
  • 1.6. Information Procurement
    • 1.6.1. Primary Research
  • 1.7. Information or Data Analysis
  • 1.8. Market Formulation & Validation
  • 1.9. Market Model
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Enzymatic DNA Synthesis Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Growing biopharmaceutical industry
      • 3.2.1.2. Rising demand for precision medicine
      • 3.2.1.3. Increasing research in synthetic biology
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. High costs of enzymatic DNA synthesis
  • 3.3. Enzymatic DNA Synthesis Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Enzymatic DNA Synthesis Market: Services Estimates & Trend Analysis

  • 4.1. Services Segment Dashboard
  • 4.2. Global Enzymatic DNA Synthesis Market Services Movement Analysis
  • 4.3. Global Enzymatic DNA Synthesis Market Size & Trend Analysis, by Services, 2018 - 2030 (USD Million)
  • 4.4. Oligonucleotide Synthesis
    • 4.4.1. Oligonucleotide synthesis market estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.5. Gene Synthesis
    • 4.5.1. Gene synthesis market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 5. Enzymatic DNA Synthesis Market: Application Estimates & Trend Analysis

  • 5.1. Application Segment Dashboard
  • 5.2. Global Enzymatic DNA Synthesis Market Application Movement Analysis
  • 5.3. Global Enzymatic DNA Synthesis Market Size & Trend Analysis, by Application, 2018 - 2030 (USD Million)
  • 5.4. Synthetic Biology
    • 5.4.1. Synthetic biology market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.5. Vaccine Development
    • 5.5.1. Vaccine development market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.6. Genetic Engineering
    • 5.6.1. Genetic engineering market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.7. Others
    • 5.7.1. Others market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 6. Enzymatic DNA Synthesis Market: End Use Estimates & Trend Analysis

  • 6.1. End Use Segment Dashboard
  • 6.2. Global Enzymatic DNA Synthesis Market End Use Movement Analysis
  • 6.3. Global Enzymatic DNA Synthesis Market Size & Trend Analysis, by End Use, 2018 - 2030 (USD Million)
  • 6.4. Biopharmaceutical Companies
    • 6.4.1. Biopharmaceutical companies market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.5. Academic & Research Institutes
    • 6.5.1. Academic & research institutes market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.6. Contract Research Organizations
    • 6.6.1. Contract research organizations market estimates and forecasts 2018 - 2030 (USD Million)

Chapter 7. Enzymatic DNA Synthesis Market: Regional Estimates & Trend Analysis by Services, Application, and End Use

  • 7.1. Regional Market Dashboard
  • 7.2. Market Size, & Forecasts Trend Analysis, 2018 - 2030
  • 7.3. North America
    • 7.3.1. North America market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.3.2. U.S.
      • 7.3.2.1. Key country dynamics
      • 7.3.2.2. Regulatory framework
      • 7.3.2.3. Competitive scenario
      • 7.3.2.4. U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.3.3. Canada
      • 7.3.3.1. Key country dynamics
      • 7.3.3.2. Regulatory framework
      • 7.3.3.3. Competitive scenario
      • 7.3.3.4. Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.4. Europe
    • 7.4.1. Europe market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.4.2. UK
      • 7.4.2.1. Key country dynamics
      • 7.4.2.2. Regulatory framework
      • 7.4.2.3. Competitive scenario
      • 7.4.2.4. UK market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.4.3. Germany
      • 7.4.3.1. Key country dynamics
      • 7.4.3.2. Regulatory framework
      • 7.4.3.3. Competitive scenario
      • 7.4.3.4. Germany market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.4.4. France
      • 7.4.4.1. Key country dynamics
      • 7.4.4.2. Regulatory framework
      • 7.4.4.3. Competitive scenario
      • 7.4.4.4. France market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.4.5. Italy
      • 7.4.5.1. Key country dynamics
      • 7.4.5.2. Regulatory framework
      • 7.4.5.3. Competitive scenario
      • 7.4.5.4. Italy market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.4.6. Spain
      • 7.4.6.1. Key country dynamics
      • 7.4.6.2. Regulatory framework
      • 7.4.6.3. Competitive scenario
      • 7.4.6.4. Spain market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.4.7. Norway
      • 7.4.7.1. Key country dynamics
      • 7.4.7.2. Regulatory framework
      • 7.4.7.3. Competitive scenario
      • 7.4.7.4. Norway market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.4.8. Sweden
      • 7.4.8.1. Key country dynamics
      • 7.4.8.2. Regulatory framework
      • 7.4.8.3. Competitive scenario
      • 7.4.8.4. Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.4.9. Denmark
      • 7.4.9.1. Key country dynamics
      • 7.4.9.2. Regulatory framework
      • 7.4.9.3. Competitive scenario
      • 7.4.9.4. Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.5.2. Japan
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Regulatory framework
      • 7.5.2.3. Competitive scenario
      • 7.5.2.4. Japan market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.5.3. China
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Regulatory framework
      • 7.5.3.3. Competitive scenario
      • 7.5.3.4. China market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.5.4. India
      • 7.5.4.1. Key country dynamics
      • 7.5.4.2. Regulatory framework
      • 7.5.4.3. Competitive scenario
      • 7.5.4.4. India market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.5.5. Australia
      • 7.5.5.1. Key country dynamics
      • 7.5.5.2. Regulatory framework
      • 7.5.5.3. Competitive scenario
      • 7.5.5.4. Australia market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.5.6. South Korea
      • 7.5.6.1. Key country dynamics
      • 7.5.6.2. Regulatory framework
      • 7.5.6.3. Competitive scenario
      • 7.5.6.4. South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.6. Latin America
    • 7.6.1. Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.6.2. Brazil
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Regulatory framework
      • 7.6.2.3. Competitive scenario
      • 7.6.2.4. Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.6.3. Chile
      • 7.6.3.1. Key country dynamics
      • 7.6.3.2. Regulatory framework
      • 7.6.3.3. Competitive scenario
      • 7.6.3.4. Chile market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.7. MEA
    • 7.7.1. MEA market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.7.2. Saudi Arabia
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Regulatory framework
      • 7.7.2.3. Competitive scenario
      • 7.7.2.4. Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.7.3. UAE
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Regulatory framework
      • 7.7.3.3. Competitive scenario
      • 7.7.3.4. UAE market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.7.4. Kuwait
      • 7.7.4.1. Key country dynamics
      • 7.7.4.2. Regulatory framework
      • 7.7.4.3. Competitive scenario
      • 7.7.4.4. Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Company/Competition Categorization
  • 8.2. Strategy Mapping
  • 8.3. Company Market Position Analysis, 2023
  • 8.4. Company Profiles/Listing
    • 8.4.1. Telesis Bio Inc.
      • 8.4.1.1. Company overview
      • 8.4.1.2. Financial performance
      • 8.4.1.3. Product benchmarking
      • 8.4.1.4. Strategic initiatives
    • 8.4.2. Twist Bioscience Corporation
      • 8.4.2.1. Company overview
      • 8.4.2.2. Financial performance
      • 8.4.2.3. Product benchmarking
      • 8.4.2.4. Strategic initiatives
    • 8.4.3. GenScript Biotech Corp.
      • 8.4.3.1. Company overview
      • 8.4.3.2. Financial performance
      • 8.4.3.3. Product benchmarking
      • 8.4.3.4. Strategic initiatives
    • 8.4.4. Evonetix
      • 8.4.4.1. Company overview
      • 8.4.4.2. Financial performance
      • 8.4.4.3. Product benchmarking
      • 8.4.4.4. Strategic initiatives
    • 8.4.5. Ansa Biotechnologies, Inc.
      • 8.4.5.1. Company overview
      • 8.4.5.2. Financial performance
      • 8.4.5.3. Product benchmarking
      • 8.4.5.4. Strategic initiatives
    • 8.4.6. Camena Bio
      • 8.4.6.1. Company overview
      • 8.4.6.2. Financial performance
      • 8.4.6.3. Product benchmarking
      • 8.4.6.4. Strategic initiatives
    • 8.4.7. Molecular Assemblies
      • 8.4.7.1. Company overview
      • 8.4.7.2. Financial performance
      • 8.4.7.3. Product benchmarking
      • 8.4.7.4. Strategic initiatives
    • 8.4.8. DNA Script
      • 8.4.8.1. Company overview
      • 8.4.8.2. Financial performance
      • 8.4.8.3. Product benchmarking
      • 8.4.8.4. Strategic initiatives
    • 8.4.9. Touchlight
      • 8.4.9.1. Company overview
      • 8.4.9.2. Financial performance
      • 8.4.9.3. Product benchmarking
      • 8.4.9.4. Strategic initiatives
    • 8.4.10. Kern Systems
      • 8.4.10.1. Company overview
      • 8.4.10.2. Financial performance
      • 8.4.10.3. Product benchmarking
      • 8.4.10.4. Strategic initiatives